|
Median overall survival (mo)
|
45.2 ± 12.1
|
14.1 ± 8.6
|
0.039
|
|
1-y overall survival (%)
|
85.7
|
53.3
| |
|
3-y overall survival (%)
|
64.1
|
26.6
| |
|
5-y overall survival (%)
|
40.2
|
20.0
| |
|
Median progression-free survival (mo)
|
21.2 ± 11.0
|
4.16 ± 2.8
|
0.007
|
|
1-y progression-free survival (%)
|
70.0
|
27
| |
|
3-y progression-free survival (%)
|
53.0
|
7
| |
|
5-y progression-free survival (%)
|
18.0
|
0.0
| |
|
Progression (case)
|
11 (73.3%)
|
15 (100%)
|
0.330
|
|
Intra-hepatic
|
1 (6.7%)
|
13 (86.7%)
| |
|
Extra-hepatic
|
7 (46.7%)
|
0
| |
|
Both intra- and extra-hepatic
|
3 (20.0%)
|
2 (13.3%)
| |
